| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |